GSK
3 years ago ⋅ English ⋅ 4 min read
Newsroom
Completion of the demerger of Haleon and share consolidation of GSK

GSK plc (LSE/NYSE: GSK) has today (Monday 18 July 2022) completed the demerger of the Consumer Healthcare business from the GSK Group to form the Haleon Group. The shares of Haleon plc... Read More
GSK
3 years ago ⋅ English ⋅ 2 min read
Newsroom
GSK gathers global experts to discuss role of vaccines in protecting people and the planet

For media and investors only- ‘Palio’ meeting, held annually by GSK, to address the growing threat to human health from infectious disease and its links to nature loss and c... Read More
GSK
3 years ago ⋅ English ⋅ 5 min read
Newsroom
Result of General Meeting

For media and investors onlyGSK plc (LSE/NYSE: GSK) is pleased to announce that at a General Meeting held at 2.30 pm on Wednesday 6 July 2022 both resolutions set out in the Notice of G... Read More
GSK
3 years ago ⋅ English ⋅ 3 min read
Newsroom
GSK completes acquisition of Sierra Oncology

For media and investors onlyIssued: 1 July 2022, London UKGSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Sierra Oncology, Inc. (Sierra Oncology), a Californ... Read More
GSK
3 years ago ⋅ English ⋅ 3 min read
Newsroom
GSK selects Target the Future grant recipient in innovation challenge supporting multiple myeloma community

For media and investors onlyInaugural grant awarded to the HealthTree Foundation, a pioneering non-profit organisation whose proposal will address disparities in care in multiple myelom... Read More
GSK
3 years ago ⋅ English ⋅ 3 min read
Newsroom
Japan’s Ministry of Health, Labour and Welfare accepts Shingrix regulatory submission to prevent shingles in at-risk adults aged 18 years and older

For media and investors only- Regulatory submission aims to expand the number of people who can be protected against shingles, including those with immunodeficiency or immunosuppression... Read More